The advancement of restriction enzymes as tools for the digestion of target genes and the invention of PCR for their specific amplification have simplified the construction of vectors for protein production (1) and the generation of large plasmid-based gene libraries for selection or screening experiments (2) in Escherichia coli. Even though a variety of vectors for these tasks are now commercially available, there is still room for improvement when it comes to cost and efficiency. First, commonly used cloning vectors lack versatility and standardization: Most vectors differ in their restriction sites; thus, re-cloning of a gene from one plasmid into another one before expression often requires additional PCR steps using dif ferent primer sets. Moreover, use of two restriction enzymes always necessitates digestion of both the gene of interest and the cloning vector followed by gel purification before ligation. Second, in the pET expression vectors, which are commonly used for protein production in E. coli (1) , NdeI is usually the choice for the 5´ cloning site, since all other restriction site sequences included in the multiple cloning site add additional amino acids between the N-terminal methionine residue and the remainder of the protein of interest. However, NdeI digestion results in only a 2-bp overhang, significantly lowering ligation ef ficiency and increasing the risk of generating false-positive clones through non-digested or re-ligated vector. T hird, some expression vectors encode unwanted linkers between purification tags and the coding sequence, which could impair function, oligomerization, or crystallization of target proteins. An example is the 10-amino acid linker between the N-terminal hexa-histidine tag and the protein of interest in pET28a vectors, which is introduced upon cloning with the restriction enzymes NdeI and XhoI. These drawbacks often render cloning in commonly used expression vectors inefficient, tedious, and time consuming. This is especially disadvantageous in directed evolution experiments for which large gene libraries with >10 8 Here, we modified the multiple cloning sites from commonly used expression vectors to create a new suite of cloning plasmids that simplify and speed up cloning procedures in Escherichia coli. Each of our standardized plasmids contains two BsaI restriction sites, allowing for highly efficient cloning of genes and bringing their expression under control of either a T7 (pET21a_BsaI, pET28a_BsaI, and pMAL-c5T_BsaI) or T5 promoter (pUR22 and pUR23). Another plasmid in our suite (pTNA_BsaI) allows for generation of large gene libraries containing >10 8 variants, which can be constitutively expressed in selection experiments using metabolic complementation of auxotrophic E. coli strains. Coupling restriction and ligation with the BsaI restriction enzyme minimizes hands-on time, while the need for only three different primers to clone a target gene into the six different vectors keeps overall cloning costs low.
Benchmarks

METHOD SUMMARY
A set of six expression vectors that simplifies cloning procedures for both protein production and the generation of large gene libraries in Escherichia coli is described. These vectors contain standardized BsaI restriction sites for highly costefficient cloning. with simultaneous and seamless ligation, thereby speeding up the cloning process. We have generated a versatile set of six novel plasmids (Supplementar y Material: Vector construction) that exploits the benefits of the Golden Gate method while simultaneously addressing the shortcomings of commonly used vectors: non-standardization of restriction sites and the addition of unnecessary amino acids to the protein coding sequence. We simplified the multiple cloning sites of 6 commercially available and commonly used vectors by introducing 2 BsaI restriction sites that leave distinct 4-bp 5´ and 3´ overhangs that are identical in all our plasmids ( Figure  1 The vectors pET21_BsaI, pET28_ BsaI, a nd p M a l-c 5T_ BsaI w e r e constructed from pET21a (Novagen/ Merck KGaA, Darmstadt, Germany), pET28a (Novagen/Merck KGaA), and pMAL-c5x (New England Biolabs, Ipswich, MA), respectively, allowing for protein production with C-or N-terminal hexa-histidine tags or maltose binding protein (MBP) fusion in E. coli strains containing a chromosomal copy of the T7 polymerase gene (Table 1) . In pET28_BsaI, three superfluous amino acids between the N-terminal tag and the start codon were removed, along with the often unnecessary thrombincleavage site between the tag and the gene of interest. This strategy left only two amino acids for increased flexibility between the N-terminal tag and the protein, analogous to the link between the protein and the C-terminal tag in pET21a and pET21_BsaI. In pMal-c5T_
BsaI, the protein of interest is fused at the N terminus to the solubilityenhancer MBP, which can be cleaved off using thrombin. Vectors pUR22 and pUR23 were constructed from a shortened pQE70 vector (Qiagen, Venlo, The Netherlands) and the lacI q fragment from pCA24N (5), allowing for protein production with the newly introduced Nand C-terminal hexa-histidine tags in E. coli strains containing no T7 polymerase gene (Table 1) .
Vector pTNA _BsaI ( (8) , which significantly increases the chances of identifying rare, beneficial combinations of mutations. Use of the promoter region of the tryptophanase operon (P TNA ) leads to low constitutive expression in all E. coli strains, allowing for in vivo selection or screening under stringent conditions.
There are a number of benefits provided by our vector set. First, the use of the same set of primers and only a single restriction enzyme for multiple vectors significantly lowers the cost of a cloning experiment. Second, the high efficiency of Golden Gate cloning, where restriction digestion and ligation are combined in a one-pot reaction, eliminates the need for gel purification of the PCR reaction. Finally, a ligation efficiency >95% makes colony PCR before sequencing dispensable, again lowering the overall cloning time and cost.
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